Payment overview · 2025
General Payments
$51.21
3 reported records · 3 companies
Healthcare provider profile · identity verified
Joseph R. Bobrowski, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · COVINGTON, LA · NPI 1609870013
Verified facts
What the public records show
CMS Open Payments records show Joseph R. Bobrowski, M.D. received $51.21 in general payments during 2025 across 3 reported records.
Dexcom, Inc. accounted for 36.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $18.46 | 36.0% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $17.15 | 33.5% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.60 | 30.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $51.21 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $18.46 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $17.15 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 691 | 230 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 661 | 257 |
| Amlodipine Besylate | Amlodipine Besylate | 531 | 211 |
| Atorvastatin Calcium | Atorvastatin Calcium | 493 | 176 |
| Pantoprazole Sodium | Pantoprazole Sodium | 427 | 169 |
| Alprazolam | Alprazolam | 406 | 109 |
| Metformin Hcl Er | Metformin Hcl | 330 | 120 |
| Losartan Potassium | Losartan Potassium | 310 | 115 |
| Gabapentin | Gabapentin | 232 | 103 |
| Zolpidem Tartrate | Zolpidem Tartrate | 228 | 56 |
| Sertraline Hcl | Sertraline Hcl | 226 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 219 | 82 |
| Alendronate Sodium | Alendronate Sodium | 206 | 76 |
| Potassium Chloride | Potassium Chloride | 182 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 182 | 68 |
| Lisinopril | Lisinopril | 174 | 59 |
| Escitalopram Oxalate | Escitalopram Oxalate | 172 | 54 |
| Trazodone Hcl | Trazodone Hcl | 169 | 65 |
| Omeprazole | Omeprazole | 166 | 63 |
| Celecoxib | Celecoxib | 162 | 94 |
| Lorazepam | Lorazepam | 162 | 38 |
| Furosemide | Furosemide | 156 | 66 |
| Montelukast Sodium | Montelukast Sodium | 153 | 62 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 149 | 53 |
| Pravastatin Sodium | Pravastatin Sodium | 148 | 47 |
| Clopidogrel | Clopidogrel Bisulfate | 142 | 53 |
| Simvastatin | Simvastatin | 139 | 49 |
| Meloxicam | Meloxicam | 138 | 66 |
| Metformin Hcl | Metformin Hcl | 128 | 49 |
| Telmisartan | Telmisartan | 128 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 125 | 63 |
| Famotidine | Famotidine | 124 | 49 |
| Glimepiride | Glimepiride | 122 | 45 |
| Mounjaro | Tirzepatide | 111 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 39 |
| Tizanidine Hcl | Tizanidine Hcl | 98 | 51 |
| Doxycycline Hyclate | Doxycycline Hyclate | 97 | 79 |
| Allopurinol | Allopurinol | 96 | 37 |
| Bupropion Xl | Bupropion Hcl | 95 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 95 | 32 |
| Eliquis | Apixaban | 94 | 33 |
| Synthroid | Levothyroxine Sodium | 93 | 28 |
| Januvia | Sitagliptin Phosphate | 91 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 90 | 42 |
| Ezetimibe | Ezetimibe | 88 | 40 |
| Tramadol Hcl | Tramadol Hcl | 88 | 35 |
| Ozempic | Semaglutide | 85 | 23 |
| Clonazepam | Clonazepam | 82 | 22 |
| Fenofibrate | Fenofibrate | 82 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 74 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 71 | 32 |
| Trulicity | Dulaglutide | 69 | 15 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 68 | 11 |
| Carvedilol | Carvedilol | 66 | 26 |
| Methylprednisolone | Methylprednisolone | 66 | 61 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 64 | 56 |
| Diclofenac Sodium | Diclofenac Sodium | 63 | 39 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 13 |
| Atenolol | Atenolol | 58 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 58 | 24 |
| Ropinirole Hcl | Ropinirole Hcl | 57 | 20 |
| Estradiol | Estradiol | 55 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 55 | 47 |
| Nateglinide | Nateglinide | 52 | 22 |
| Finasteride | Finasteride | 50 | 23 |
| Temazepam | Temazepam | 49 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 48 | suppressed |
| Levofloxacin | Levofloxacin | 48 | 43 |
| Cefuroxime | Cefuroxime Axetil | 47 | 43 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | 18 |
| Mupirocin | Mupirocin | 46 | 32 |
| Buspirone Hcl | Buspirone Hcl | 45 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 44 | 21 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 43 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 42 | 14 |
| Azelastine Hcl | Azelastine Hcl | 41 | 19 |
| Benazepril Hcl | Benazepril Hcl | 41 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 41 | 24 |
| Pregabalin | Pregabalin | 41 | 14 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 41 | 19 |
| Donepezil Hcl | Donepezil Hcl | 39 | 14 |
| Testosterone Cypionate | Testosterone Cypionate | 39 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 36 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | 12 |
| Metronidazole | Metronidazole | 34 | 32 |
| Ondansetron Odt | Ondansetron | 34 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | 12 |
| Prednisone | Prednisone | 33 | 26 |
| Valsartan | Valsartan | 33 | 15 |
| Zaleplon | Zaleplon | 33 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 32 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 32 | 13 |
| Ramipril | Ramipril | 31 | 11 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Memantine Hcl | Memantine Hcl | 30 | suppressed |
| Vascepa | Icosapent Ethyl | 29 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 25 |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 19 |
| Fluconazole | Fluconazole | 24 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 23 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 22 | 18 |
| Methenamine Hippurate | Methenamine Hippurate | 21 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Dutasteride | Dutasteride | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 18 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 15 |
| Colchicine | Colchicine | 16 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 15 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 11 |
| Primidone | Primidone | 14 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Dextroamphetamine Sulfate | Dextroamphetamine Sulfate | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $51.21 · 3 records | Dexcom, Inc. | Cologuard Collection Kit, Dexcom G6 Transmitter, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error